Comparison between 18F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trial

Comparison between 18F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trial

Objective: This study aimed to compare the upgrade rate and cancer detection rate between the 18F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy (TB) and systematic biopsy in selected patients with suspected prostate cancer (the molecular imaging prostate-specific membrane antigen score of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shaoxi Niu, Yachao Liu, Liyan Ao, Xiaohui Ding, Xiao Chang, Jinhang Li, Jiajin Liu, Kan Liu, Nanxing Zou, Baixuan Xu, Yong Xu, Baojun Wang, Xu Zhang
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Asian Journal of Urology
Subjects:	Prostatic neoplasm 18F-DCFPyL PET Targeted biopsy Prostate-specific membrane antigen
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388224001206
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases
by: Theresa Jung, et al.
Published: (2025-01-01)

Impact of delayed pelvic imaging on the staging of biochemical recurrence in prostate cancer patients using [18F]DCFPYL PET/CT: a retrospective evaluation
by: Ana Rodríguez-Pajuelo, et al.
Published: (2025-02-01)

Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01)

The initial results of MRI-TRUS fusion prostate biopsy in high volume tertiary center
by: Smrkolj Tomaz, et al.
Published: (2024-11-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer
by: Carolin Siech, et al.
Published: (2025-02-01)

Personalized optimization of systematic prostate biopsy core number based on mpMRI radiomics features: a large-sample retrospective analysis
by: Zhenlin Chen, et al.
Published: (2025-01-01)

A new ASAP Scoring System and Risk Table to predict second prostate biopsy outcomes
by: Ediz Caner, et al.
Published: (2021-10-01)

Comparison of Post Biopsy Pathology and Post Radical Prostatectomy Pathology in Patients with Prostate Cancer Detected After Fusion Biopsy
by: Serdar Göktaş, et al.
Published: (2023-10-01)

The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
by: Tzu-Heng Huang, et al.
Published: (2025-02-01)

Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy
by: Alfred Honoré, et al.
Published: (2025-01-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

The diagnostic performance of indocyanine green for the sentinel node biopsy in prostate cancer: A systematic review and meta-analysis
by: Siyang Ma, et al.
Published: (2025-01-01)

Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects
by: Yutong Liu, et al.
Published: (2025-01-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study
by: Le Ma, et al.
Published: (2025-01-01)

Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT: a comparison to MRI using histopathology as reference
by: Erland Hvittfeldt, et al.
Published: (2025-01-01)

First Experiences with Fusion of PET-CT and MRI Datasets for Navigation-Assisted Percutaneous Biopsies for Primary and Metastatic Bone Tumors
by: Hagen Fritzsche, et al.
Published: (2024-12-01)

The impact of preliminary patient hydration on physiological [18F]PSMA-1007 uptake in the urinary bladder on PET/CT
by: T. L. Antonevskaya, et al.
Published: (2024-06-01)

Development of novel nomograms for predicting prostate cancer in biopsy-naive patients with PSA < 10 ng/ml and PI-RADS ≤ 3 lesions
by: Jia-gui Chai, et al.
Published: (2025-01-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Evaluating [<sup>68</sup>Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study
by: Andrea Di Giorgio, et al.
Published: (2024-12-01)

Molecular mechanisms impact on fluoroquinolone resistance among E.coli from enteric carriage monitoring before prostate biopsy and earliest description of qnrB81
by: Rehaiem Amel, et al.
Published: (2024-11-01)

Antegrade Endobiliary Forceps Biopsy Improves Diagnosis of Klatskin Tumor Compared to Brush Biopsy
by: A. V. Kozlov, et al.
Published: (2022-08-01)

Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma
by: Ilham Badrane, et al.
Published: (2024-12-01)

Diagnostic accuracy of 18F Prostate Specific Membrane Antigen (PSMA) PET-CT radiotracers in staging and restaging of high-risk prostate cancer patients and patients with biochemical recurrence: protocol for an overview of reviews [version 2; peer review: 2 approved]
by: Susan Ahern, et al.
Published: (2025-01-01)

Incidental discovery of gastrointestinal stromal tumor via PSMA-PET/CT imaging: Insights from a case report
by: Venetia A. Florou, et al.
Published: (2025-01-01)

Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
by: Shashwat Pandey, et al.
Published: (2025-01-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

A case of stromal sarcoma of the prostate with the incidental detection of prostate adenocarcinoma
by: Shang Xu, et al.
Published: (2025-03-01)

A Case of Cavitary Lung Metastasis From Prostate Cancer
by: Shinnosuke Ohnaka, et al.
Published: (2025-01-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer
by: Marco M. E. Vogel, et al.
Published: (2025-01-01)

Liquid biopsy - a review
by: WERONIKA RUTKOWSKA-KAWALEC, et al.
Published: (2025-01-01)

Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET/CT
by: Chong Jiang, et al.
Published: (2025-01-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
by: Agnieszka Krzyzanowska, et al.
Published: (2025-01-01)

Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
by: Dae Yul Yang, et al.
Published: (2025-01-01)

Value of original and modified pathological scoring systems for prognostic prediction in paraffin-embedded donor kidney core biopsy
by: Jinghong Tan, et al.
Published: (2024-12-01)